{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:13:46Z","timestamp":1783703626257,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R34MH119007"],"award-info":[{"award-number":["R34MH119007"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F30AI152342"],"award-info":[{"award-number":["F30AI152342"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.japh.2024.102239","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T07:38:11Z","timestamp":1725521891000},"page":"102239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Feasibility of reaching populations at high risk for HIV in community pharmacies"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4859-6304","authenticated-orcid":false,"given":"Natalie D.","family":"Crawford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9306-4980","authenticated-orcid":false,"given":"Kristin R.V.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9471-5749","authenticated-orcid":false,"given":"Christina","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9970-7265","authenticated-orcid":false,"given":"Daniel I.","family":"Alohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7494-1450","authenticated-orcid":false,"given":"Alvan","family":"Quamina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5816-004X","authenticated-orcid":false,"given":"Omarri","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry N.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.japh.2024.102239_bib1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.japh.2015.11.008","article-title":"Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness","volume":"56","author":"Klepser","year":"2016","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"7","key":"10.1016\/j.japh.2024.102239_bib2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2105\/AJPH.2021.306314","article-title":"Support pharmacy infrastructure to strengthen US COVID-19 vaccination efforts and beyond","volume":"111","author":"Marwitz","year":"2021","journal-title":"Am J Public Health"},{"issue":"10","key":"10.1016\/j.japh.2024.102239_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz365","article-title":"Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PrEP) program in the Midwestern United States","volume":"6","author":"Havens","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.japh.2024.102239_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/apc.2019.0235","article-title":"A\u00a0pharmacist-led, same-Day, HIV pre-exposure prophylaxis Initiation program to increase PrEP uptake and Decrease time to PrEP Initiation","volume":"34","author":"Khosropour","year":"2020","journal-title":"AIDS Patient Care STDS"},{"issue":"6","key":"10.1016\/j.japh.2024.102239_bib6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2105\/AJPH.2019.305057","article-title":"Pharmacists in HIV prevention: an untapped potential","volume":"109","author":"Myers","year":"2019","journal-title":"Am J Public Health"},{"issue":"8","key":"10.1016\/j.japh.2024.102239_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/apc.2015.0017","article-title":"Evaluation of pharmacy-based HIV testing in a high-risk New York City community","volume":"29","author":"Amesty","year":"2015","journal-title":"AIDS Patient Care STDS"},{"issue":"6","key":"10.1016\/j.japh.2024.102239_bib8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1071\/SH18084","article-title":"Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care","volume":"15","author":"Tung","year":"2018","journal-title":"Sex Health"},{"issue":"1","key":"10.1016\/j.japh.2024.102239_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1331\/JAPhA.2015.14070","article-title":"Pharmacist-provided rapid HIV testing in two community pharmacies","volume":"55","author":"Darin","year":"2015","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2024.102239_bib10","series-title":"National HIV\/AIDS strategy for the United States 2022-2025","year":"2021"},{"issue":"9","key":"10.1016\/j.japh.2024.102239_bib11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV epidemic: a plan for the United States","volume":"321","author":"Fauci","year":"2019","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.japh.2024.102239_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/00333549161310S116","article-title":"Pharmacy intervention to improve HIV testing uptake using a comprehensive health screening approach","volume":"131","author":"Crawford","year":"2016","journal-title":"Public Health Rep"},{"issue":"2","key":"10.1016\/j.japh.2024.102239_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.japh.2022.11.004","article-title":"Examining pharmacies\u2019 ability to increase pre-exposure prophylaxis access for black men who have sex with men in the United States","volume":"63","author":"Alohan","year":"2023","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"5","key":"10.1016\/j.japh.2024.102239_bib14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/0897190020904590","article-title":"Willingness to discuss and screen for pre-exposure prophylaxis in pharmacies among men who have sex with men","volume":"34","author":"Crawford","year":"2021","journal-title":"J\u00a0Pharm Pract"},{"issue":"2","key":"10.1016\/j.japh.2024.102239_bib15","doi-asserted-by":"crossref","DOI":"10.2196\/35590","article-title":"Integrating and disseminating pre-exposure prophylaxis (PrEP) screening and dispensing for black men who have sex with men in Atlanta, Georgia: Protocol for community pharmacies","volume":"11","author":"Crawford","year":"2022","journal-title":"JMIR Res Protoc"},{"issue":"10","key":"10.1016\/j.japh.2024.102239_bib16","doi-asserted-by":"crossref","DOI":"10.2196\/23173","article-title":"A\u00a0data visualization and dissemination resource to support HIV prevention and care at the local level: analysis and uses of the AIDSVu public data resource","volume":"22","author":"Sullivan","year":"2020","journal-title":"J\u00a0Med Internet Res"},{"issue":"1","key":"10.1016\/j.japh.2024.102239_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-021-10996-2","article-title":"Awareness and acceptability of HIV pre-exposure prophylaxis (PrEP) among students at two historically Black universities (HBCU): a cross-sectional survey","volume":"21","author":"Okeke","year":"2021","journal-title":"BMC Publ Health"},{"issue":"4","key":"10.1016\/j.japh.2024.102239_bib18","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s10461-018-02385-5","article-title":"Barriers to HIV testing: patient and provider perspectives in the deep south","volume":"23","author":"Wise","year":"2019","journal-title":"AIDS Behav"},{"issue":"22","key":"10.1016\/j.japh.2024.102239_bib19","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.3390\/ijerph16224411","article-title":"Congruence between hypothetical willingness to use pre-exposure prophylaxis (PrEP) and eligibility: an online survey among Belgian men having sex with men","volume":"16","author":"Bullinger","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.japh.2024.102239_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.japh.2019.06.021","article-title":"Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health","volume":"60","author":"Lopez","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"6","key":"10.1016\/j.japh.2024.102239_bib22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.japh.2020.03.013","article-title":"Patient perception of community pharmacists prescribing pre-exposure prophylaxis for HIV prevention","volume":"60","author":"Zhu","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"4","key":"10.1016\/j.japh.2024.102239_bib23","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.japh.2019.12.003","article-title":"Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men","volume":"60","author":"Crawford","year":"2020","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.japh.2024.102239_bib24","article-title":"Functional knowledge of pre-exposure prophylaxis for HIV prevention among participants in a web-based survey of sexually active gay, bisexual, and other men who have sex with men: cross-sectional study","volume":"4","author":"Kahle","year":"2018","journal-title":"JMIR public Heal Surveill"},{"issue":"1","key":"10.1016\/j.japh.2024.102239_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/2331205X.2016.1256850","article-title":"Perceptions of pre-exposure prophylaxis (PrEP) among HIV-negative and HIV-positive men who have sex with men (MSM)","volume":"3","author":"Jaspal","year":"2016","journal-title":"Cogent Med"},{"issue":"6","key":"10.1016\/j.japh.2024.102239_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/lgbt.2015.0069","article-title":"Misunderstanding of pre-exposure prophylaxis use among men who have sex with men: public health and policy implications","volume":"3","author":"Kurtz","year":"2016","journal-title":"LGBT Health"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912400267X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912400267X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:08:54Z","timestamp":1736302134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154431912400267X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S154431912400267X"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.102239","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of reaching populations at high risk for HIV in community pharmacies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"102239"}}